Microdosing Collective, the first non-profit in the U.S. dedicated to establishing a legal framework for microdosing psychedelics, today announced the addition of Sam Chapman as its new Policy and ...
Booster Therapeutics, a biotechnology company pioneering a new class of proteasome activator medicines to treat neurodegenerative and other diseases, launched today with the support of a $15 million ...